Portage Biotech Inc. (PRTG)
$559.80-0.57%Close
SELLCRISIS · day 2
Key stats
- Market cap
- $1.3B
- Beta
- 0.64
- P/E (TTM)
- -1.63
- 1W
- -0.64%
- 1M
- -19.45%
- vs SPY 1W
- -0.50%
- vs SPY 1M
- -21.96%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 3
- VALUE
- 5
- GROWTH
- 15
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-197.8%
GROSS100
OP-23810
NET-39821
[VALUATION]
P/E TTM-1.63
P/E FWD-
SECTOR PE20.34
INDUSTRY PE13.84
P/B8.71
P/FCF-
EV/EBITDA-1.81
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E1.91
ALTMAN Z-
CURR RATIO0.31
ND/EBITDA-
BETA0.64
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on PRTG?
- LOPJLB’s latest quantitative signal on Portage Biotech Inc. (PRTG) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is PRTG in?
- Portage Biotech Inc. (PRTG) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Portage Biotech Inc. (PRTG) do?
- Portage Biotech Inc., operating through its various subsidiaries, focuses on the discovery and advancement of novel pharmaceutical and biotechnological products. The company's extensive pipeline includes several key therapeutic candidates and platforms. Among these are IMM60, an activator for iNKT cells; IMM65, a specialized PLGA-nanoparticle integrated with a NY-ESO-1 peptide vaccine; and INT2…